Seryx Biomedical Inc - MN Hennepin, Minneapolis 55441

Seryx Biomedical Inc entered the industry of Medical Research in 2010 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 541720, which describes it as a Medical Research. For further clarification, the SIC classifies this business under the code 8733 and described it as a Medical Research. The business provides service to the B2B market.

To acquire more information, please contact Brian Lawrence by calling (407) 348-4527 during business hours. You can also write to the business’ Single Location at 10900 73rd Avenue North # 100, Minneapolis, Minnesota MN 55441. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Seryx Biomedical Inc
Representative: Brian Lawrence
Place of Business: 10900 73rd Avenue North # 100, Minneapolis, MN 55441
Contact Number: (407) 348-4527
Type of Service: Medical Research
SIC Number: 8733
NAICS Number: 541720
Locality: Single Location
Market Type: B2B (Business to Business)
Began: 2010
Income/Year: $100.000 to $499.999
Laborers: 1 to 4
Share This Company:

Seryx Biomedical Inc is a company operating from Hennepin, Minnesota providing professional Medical Research and relevant B2B variables. It was founded in 2010 and registered with the SIC code 8733 as Medical Research, and with the NAICS code 541720 as Medical Research.

With a current employee count of 1 to 4, Seryx Biomedical Inc has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Brian Lawrence at (407) 348-4527 for related queries, or to locate its Single Location using the coordinates 45.086142,-93.418423.

The Single Location can also be found at the street address 10900 73rd Avenue North # 100 in Minneapolis, Minnesota 55441 and can be engaged online through the company website at , the company Twitter , and Facebook page .